<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">38748469</PMID><DateCompleted><Year>2024</Year><Month>05</Month><Day>15</Day></DateCompleted><DateRevised><Year>2024</Year><Month>06</Month><Day>01</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2369-2960</ISSN><JournalIssue CitedMedium="Internet"><Volume>10</Volume><PubDate><Year>2024</Year><Month>May</Month><Day>15</Day></PubDate></JournalIssue><Title>JMIR public health and surveillance</Title><ISOAbbreviation>JMIR Public Health Surveill</ISOAbbreviation></Journal><ArticleTitle>Persistence and Variation of the Indirect Effects of COVID-19 Restrictions on the Spectrum of Notifiable Infectious Diseases in China: Analysis of National Surveillance Among Children and Adolescents From 2018 to 2021.</ArticleTitle><Pagination><StartPage>e47626</StartPage><MedlinePgn>e47626</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e47626</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.2196/47626</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Beyond the direct effect of COVID-19 infection on young people, the wider impact of the pandemic on other infectious diseases remains unknown.</AbstractText><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">This study aims to assess changes in the incidence and mortality of 42 notifiable infectious diseases during the pandemic among children and adolescents in China, compared with prepandemic levels.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">The Notifiable Infectious Disease Surveillance System of China was used to detect new cases and fatalities among individuals aged 5-22 years across 42 notifiable infectious diseases spanning from 2018 to 2021. These infectious diseases were categorized into 5 groups: respiratory, gastrointestinal and enterovirus, sexually transmitted and blood-borne, zoonotic, and vector-borne diseases. Each year (2018-2021) was segmented into 4 phases: phase 1 (January 1-22), phase 2 (January 23-April 7), phase 3 (April 8-August 31), and phase 4 (September 1-December 31) according to the varying intensities of pandemic restrictive measures in 2020. Generalized linear models were applied to assess the change in the incidence and mortality within each disease category, using 2018 and 2019 as the reference.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">A total of 4,898,260 incident cases and 3701 deaths were included. The overall incidence of notifiable infectious diseases decreased sharply during the first year of the COVID-19 pandemic (2020) compared with prepandemic levels (2018 and 2019), and then rebounded in 2021, particularly in South China. Across the past 4 years, the number of deaths steadily decreased. The incidence of diseases rebounded differentially by the pandemic phase. For instance, although seasonal influenza dominated respiratory diseases in 2019, it showed a substantial decline during the pandemic (percent change in phase 2 2020: 0.21, 95% CI 0.09-0.50), which persisted until 2021 (percent change in phase 4 2021: 1.02, 95% CI 0.74-1.41). The incidence of gastrointestinal and enterovirus diseases decreased by 33.6% during 2020 but rebounded by 56.9% in 2021, mainly driven by hand, foot, and mouth disease (percent change in phase 3 2021: 1.28, 95% CI 1.17-1.41) and infectious diarrhea (percent change in phase 3 2020: 1.22, 95% CI 1.17-1.28). Sexually transmitted and blood-borne diseases were restrained during the first year of 2021 but rebounded quickly in 2021, mainly driven by syphilis (percent change in phase 3 2020: 1.31, 95% CI 1.23-1.40) and gonorrhea (percent change in phase 3 2020: 1.10, 95% CI 1.05-1.16). Zoonotic diseases were not dampened by the pandemic but continued to increase across the study period, mainly due to brucellosis (percent change in phase 2 2020: 0.94, 95% CI 0.75-1.16). Vector-borne diseases showed a continuous decline during 2020, dominated by hemorrhagic fever (percent change in phase 2 2020: 0.68, 95% CI 0.53-0.87), but rebounded in 2021.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">The COVID-19 pandemic was associated with a marked decline in notifiable infectious diseases in Chinese children and adolescents. These effects were not sustained, with evidence of a rebound to prepandemic levels by late 2021. To effectively address the postpandemic resurgence of infectious diseases in children and adolescents, it will be essential to maintain disease surveillance and strengthen the implementation of various initiatives. These include extending immunization programs, prioritizing the management of sexually transmitted infections, continuing feasible nonpharmaceutical intervention projects, and effectively managing imported infections.</AbstractText><CopyrightInformation>©Li Chen, Liping Wang, Yi Xing, Junqing Xie, Binbin Su, Mengjie Geng, Xiang Ren, Yi Zhang, Jieyu Liu, Tao Ma, Manman Chen, Jessica E Miller, Yanhui Dong, Yi Song, Jun Ma, Susan Sawyer. Originally published in JMIR Public Health and Surveillance (https://publichealth.jmir.org), 15.05.2024.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Chen</LastName><ForeName>Li</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0002-8607-8997</Identifier><AffiliationInfo><Affiliation>Institute of Child and Adolescent Health, School of Public Health, National Health Commission Key Laboratory of Reproductive Health, Peking University, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Wang</LastName><ForeName>Liping</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0002-7488-6567</Identifier><AffiliationInfo><Affiliation>Division of Infectious Disease Control and Prevention, Key Laboratory of Surveillance and Early Warning on Infectious Disease, Chinese Center for Disease Control and Prevention, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Xing</LastName><ForeName>Yi</ForeName><Initials>Y</Initials><Identifier Source="ORCID">0000-0002-4076-2945</Identifier><AffiliationInfo><Affiliation>Institute of Child and Adolescent Health, School of Public Health, National Health Commission Key Laboratory of Reproductive Health, Peking University, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xie</LastName><ForeName>Junqing</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0002-0040-0042</Identifier><AffiliationInfo><Affiliation>Centre for Statistics in Medicine, Nuffield Department of Orthopaedics Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Su</LastName><ForeName>Binbin</ForeName><Initials>B</Initials><Identifier Source="ORCID">0000-0003-1814-024X</Identifier><AffiliationInfo><Affiliation>Institute of Population Research, Peking University Asia-Pacific Economic Cooperation Health Sciences Academy, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Geng</LastName><ForeName>Mengjie</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0003-2578-940X</Identifier><AffiliationInfo><Affiliation>Division of Infectious Disease Control and Prevention, Key Laboratory of Surveillance and Early Warning on Infectious Disease, Chinese Center for Disease Control and Prevention, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ren</LastName><ForeName>Xiang</ForeName><Initials>X</Initials><Identifier Source="ORCID">0000-0001-5020-5838</Identifier><AffiliationInfo><Affiliation>Division of Infectious Disease Control and Prevention, Key Laboratory of Surveillance and Early Warning on Infectious Disease, Chinese Center for Disease Control and Prevention, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Yi</ForeName><Initials>Y</Initials><Identifier Source="ORCID">0009-0009-0726-693X</Identifier><AffiliationInfo><Affiliation>Institute of Child and Adolescent Health, School of Public Health, National Health Commission Key Laboratory of Reproductive Health, Peking University, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Jieyu</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0001-6584-1191</Identifier><AffiliationInfo><Affiliation>Institute of Child and Adolescent Health, School of Public Health, National Health Commission Key Laboratory of Reproductive Health, Peking University, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ma</LastName><ForeName>Tao</ForeName><Initials>T</Initials><Identifier Source="ORCID">0009-0006-4604-7498</Identifier><AffiliationInfo><Affiliation>Institute of Child and Adolescent Health, School of Public Health, National Health Commission Key Laboratory of Reproductive Health, Peking University, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Manman</ForeName><Initials>M</Initials><Identifier Source="ORCID">0009-0004-8446-2188</Identifier><AffiliationInfo><Affiliation>Institute of Child and Adolescent Health, School of Public Health, National Health Commission Key Laboratory of Reproductive Health, Peking University, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Miller</LastName><ForeName>Jessica E</ForeName><Initials>JE</Initials><Identifier Source="ORCID">0000-0002-1806-1894</Identifier><AffiliationInfo><Affiliation>Department of Paediatrics, University of Melbourne, Melbourne, Victoria, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Murdoch Children's Research Institute, Royal Children's Hospital, Parkville, Victoria, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dong</LastName><ForeName>Yanhui</ForeName><Initials>Y</Initials><Identifier Source="ORCID">0000-0003-2519-3200</Identifier><AffiliationInfo><Affiliation>Institute of Child and Adolescent Health, School of Public Health, National Health Commission Key Laboratory of Reproductive Health, Peking University, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Song</LastName><ForeName>Yi</ForeName><Initials>Y</Initials><Identifier Source="ORCID">0000-0001-6990-6781</Identifier><AffiliationInfo><Affiliation>Institute of Child and Adolescent Health, School of Public Health, National Health Commission Key Laboratory of Reproductive Health, Peking University, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ma</LastName><ForeName>Jun</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0003-3529-1808</Identifier><AffiliationInfo><Affiliation>Institute of Child and Adolescent Health, School of Public Health, National Health Commission Key Laboratory of Reproductive Health, Peking University, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sawyer</LastName><ForeName>Susan</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0002-9095-358X</Identifier><AffiliationInfo><Affiliation>Department of Paediatrics, University of Melbourne, Melbourne, Victoria, Australia.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>05</Month><Day>15</Day></ArticleDate></Article><MedlineJournalInfo><Country>Canada</Country><MedlineTA>JMIR Public Health Surveill</MedlineTA><NlmUniqueID>101669345</NlmUniqueID><ISSNLinking>2369-2960</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002681" MajorTopicYN="N" Type="Geographic">China</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003141" MajorTopicYN="N">Communicable Diseases</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018563" MajorTopicYN="N">Disease Notification</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">children and adolescents</Keyword><Keyword MajorTopicYN="N">notifiable infectious diseases</Keyword></KeywordList><CoiStatement>Conflicts of Interest: None declared.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>3</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>2</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>2</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>5</Month><Day>15</Day><Hour>18</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>5</Month><Day>15</Day><Hour>12</Hour><Minute>45</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>5</Month><Day>15</Day><Hour>11</Hour><Minute>53</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>5</Month><Day>15</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38748469</ArticleId><ArticleId IdType="pmc">PMC11137434</ArticleId><ArticleId IdType="doi">10.2196/47626</ArticleId><ArticleId IdType="pii">v10i1e47626</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Age Structure - UNCTAD Handbook of Statistics 2021. UNCTAD. 2021.  [2024-04-10].  
 https://hbs.unctad.org/age-structure/
</Citation></Reference><Reference><Citation>Yang S, Wu J, Ding C, Cui Y, Zhou Y, Li Y, Deng M, Wang C, Xu K, Ren J, Ruan B, Li L. Epidemiological features of and changes in incidence of infectious diseases in China in the first decade after the SARS outbreak: an observational trend study. Lancet Infect Dis. 2017 Jul;17(7):716–725. doi: 10.1016/S1473-3099(17)30227-X. 
 
S1473-3099(17)30227-X</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(17)30227-X</ArticleId><ArticleId IdType="pmc">PMC7164789</ArticleId><ArticleId IdType="pubmed">28412150</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Y, Morgenstern C, Kelly J, Lowe R, CMMID COVID-19 Working Group. Jit Mark. The impact of non-pharmaceutical interventions on SARS-CoV-2 transmission across 130 countries and territories. BMC Med. 2021 Feb 05;19(1):40. doi: 10.1186/s12916-020-01872-8. 
 
10.1186/s12916-020-01872-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12916-020-01872-8</ArticleId><ArticleId IdType="doi">10.1186/s12916-020-01872-8</ArticleId><ArticleId IdType="pmc">PMC7861967</ArticleId><ArticleId IdType="pubmed">33541353</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Y, Campbell H, Kulkarni D, Harpur A, Nundy M, Wang X, Nair H. The temporal association of introducing and lifting non-pharmaceutical interventions with the time-varying reproduction number (R) of SARS-CoV-2: a modelling study across 131 countries. The Lancet Infectious Diseases. 2021 Feb;21(2):193–202. doi: 10.1016/s1473-3099(20)30785-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s1473-3099(20)30785-4</ArticleId><ArticleId IdType="pmc">PMC7581351</ArticleId><ArticleId IdType="pubmed">33729915</ArticleId></ArticleIdList></Reference><Reference><Citation>Odusanya OO, Odugbemi BA, Odugbemi TO, Ajisegiri WS. COVID-19: a review of the effectiveness of non-pharmacological interventions. Niger Postgrad Med J. 2020;27(4):261–267. doi: 10.4103/npmj.npmj_208_20.NigerPostgradMedJ_2020_27_4_261_299904</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/npmj.npmj_208_20</ArticleId><ArticleId IdType="pubmed">33154276</ArticleId></ArticleIdList></Reference><Reference><Citation>Dong Y, Mo X, Hu Y, Qi X, Jiang F, Jiang Z, Tong Shilu. Epidemiology of COVID-19 among children in China. Pediatrics. 2020 Jun;145(6):e20200702. doi: 10.1542/peds.2020-0702.peds.2020-0702</Citation><ArticleIdList><ArticleId IdType="doi">10.1542/peds.2020-0702</ArticleId><ArticleId IdType="pubmed">32179660</ArticleId></ArticleIdList></Reference><Reference><Citation>Bo Y, Guo C, Lin C, Zeng Y, Li HB, Zhang Y, Hossain MS, Chan JWM, Yeung DW, Kwok KO, Wong SYS, Lau AKH, Lao XQ. Effectiveness of non-pharmaceutical interventions on COVID-19 transmission in 190 countries from 23 January to 13 April 2020. Int J Infect Dis. 2021 Jan;102:247–253. doi: 10.1016/j.ijid.2020.10.066. 
 
S1201-9712(20)32270-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2020.10.066</ArticleId><ArticleId IdType="pmc">PMC7598763</ArticleId><ArticleId IdType="pubmed">33129965</ArticleId></ArticleIdList></Reference><Reference><Citation>Mendez-Brito A, El Bcheraoui C, Pozo-Martin F. Systematic review of empirical studies comparing the effectiveness of non-pharmaceutical interventions against COVID-19. J Infect. 2021 Sep;83(3):281–293. doi: 10.1016/j.jinf.2021.06.018. 
 
S0163-4453(21)00316-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jinf.2021.06.018</ArticleId><ArticleId IdType="pmc">PMC8214911</ArticleId><ArticleId IdType="pubmed">34161818</ArticleId></ArticleIdList></Reference><Reference><Citation>Hsiang S, Allen D, Annan-Phan S, Bell K, Bolliger I, Chong T, Druckenmiller H, Huang LY, Hultgren A, Krasovich E, Lau P, Lee J, Rolf E, Tseng J, Wu T. The effect of large-scale anti-contagion policies on the COVID-19 pandemic. Nature. 2020 Aug;584(7820):262–267. doi: 10.1038/s41586-020-2404-8.10.1038/s41586-020-2404-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-2404-8</ArticleId><ArticleId IdType="pubmed">32512578</ArticleId></ArticleIdList></Reference><Reference><Citation>Utamura M, Koizumi M, Kirikami S. An epidemiological model considering isolation to predict COVID-19 trends in Tokyo, Japan: numerical analysis. JMIR Public Health Surveill. 2020 Dec 16;6(4):e23624. doi: 10.2196/23624. 
 
v6i4e23624</Citation><ArticleIdList><ArticleId IdType="doi">10.2196/23624</ArticleId><ArticleId IdType="pmc">PMC7746226</ArticleId><ArticleId IdType="pubmed">33259325</ArticleId></ArticleIdList></Reference><Reference><Citation>Sahoo DP, Singh AK, Sahu DP, Pradhan SK, Patro BK, Batmanabane G, Mishra B, Behera B, Das A, Dora GS, Anand L, Azhar SM, Nair J, Panigrahi S, Akshaya R, Sahoo BK, Sahu S, Sahoo S. Hospital-based contact tracing of patients with COVID-19 and health care workers during the COVID-19 pandemic in eastern India: cross-sectional study. JMIR Form Res. 2021 Oct 21;5(10):e28519. doi: 10.2196/28519. 
 
v5i10e28519</Citation><ArticleIdList><ArticleId IdType="doi">10.2196/28519</ArticleId><ArticleId IdType="pmc">PMC8534486</ArticleId><ArticleId IdType="pubmed">34596569</ArticleId></ArticleIdList></Reference><Reference><Citation>Jüni Peter, Rothenbühler Martina, Bobos P, Thorpe KE, da Costa BR, Fisman DN, Slutsky AS, Gesink D. Impact of climate and public health interventions on the COVID-19 pandemic: a prospective cohort study. CMAJ. 2020 May 25;192(21):E566–E573. doi: 10.1503/cmaj.200920. 
 
cmaj.200920</Citation><ArticleIdList><ArticleId IdType="doi">10.1503/cmaj.200920</ArticleId><ArticleId IdType="pmc">PMC7259972</ArticleId><ArticleId IdType="pubmed">32385067</ArticleId></ArticleIdList></Reference><Reference><Citation>Islam N, Sharp SJ, Chowell G, Shabnam S, Kawachi I, Lacey B, Massaro JM, D'Agostino RB, White M. Physical distancing interventions and incidence of coronavirus disease 2019: natural experiment in 149 countries. BMJ. 2020 Jul 15;370:m2743. doi: 10.1136/bmj.m2743. 
 
</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.m2743</ArticleId><ArticleId IdType="pmc">PMC7360923</ArticleId><ArticleId IdType="pubmed">32669358</ArticleId></ArticleIdList></Reference><Reference><Citation>Todd IMF, Miller JE, Rowe SL, Burgner DP, Sullivan SG. Changes in infection-related hospitalizations in children following pandemic restrictions: an interrupted time-series analysis of total population data. Int J Epidemiol. 2021 Nov 10;50(5):1435–1443. doi: 10.1093/ije/dyab101. 
 
6289851</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ije/dyab101</ArticleId><ArticleId IdType="pmc">PMC8195105</ArticleId><ArticleId IdType="pubmed">34056664</ArticleId></ArticleIdList></Reference><Reference><Citation>Li ZJ, Yu LJ, Zhang HY, Shan CX, Lu QB, Zhang XA, Ren X, Zhang CH, Wang YF, Lin SH, Xu Q, Jiang BG, Jiang T, Lv CL, Chen JJ, Gao GF, Yang WZ, Wang LP, Yang Y, Fang LQ, Liu W, Chinese Centers for Disease ControlPrevention (CDC) Etiology Surveillance Study Team of Acute Respiratory Infections  Broad impacts of coronavirus disease 2019 (COVID-19) pandemic on acute respiratory infections in China: an observational study. Clin Infect Dis. 2022 Aug 24;75(1):e1054–e1062. doi: 10.1093/cid/ciab942. 
 
6426178</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciab942</ArticleId><ArticleId IdType="pmc">PMC8767888</ArticleId><ArticleId IdType="pubmed">34788811</ArticleId></ArticleIdList></Reference><Reference><Citation>Kadambari S, Goldacre R, Morris E, Goldacre MJ, Pollard AJ. Indirect effects of the covid-19 pandemic on childhood infection in England: population based observational study. BMJ. 2022 Jan 12;376:e067519. doi: 10.1136/bmj-2021-067519. 
 
</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj-2021-067519</ArticleId><ArticleId IdType="pmc">PMC8753487</ArticleId><ArticleId IdType="pubmed">35022215</ArticleId></ArticleIdList></Reference><Reference><Citation>Sakamoto H, Ishikane M, Ueda P. Seasonal influenza activity during the SARS-CoV-2 outbreak in Japan. JAMA. 2020 May 19;323(19):1969–1971. doi: 10.1001/jama.2020.6173. 
 
2764657</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.6173</ArticleId><ArticleId IdType="pmc">PMC7149351</ArticleId><ArticleId IdType="pubmed">32275293</ArticleId></ArticleIdList></Reference><Reference><Citation>Gillies MB, Burgner DP, Ivancic L, Nassar N, Miller JE, Sullivan SG, Todd IMF, Pearson S, Schaffer AL, Zoega H. Changes in antibiotic prescribing following COVID-19 restrictions: lessons for post-pandemic antibiotic stewardship. Br J Clin Pharmacol. 2022 Mar;88(3):1143–1151. doi: 10.1111/bcp.15000. 
 
</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/bcp.15000</ArticleId><ArticleId IdType="pmc">PMC8444718</ArticleId><ArticleId IdType="pubmed">34405427</ArticleId></ArticleIdList></Reference><Reference><Citation>Geng M, Zhang H, Yu L, Lv C, Wang T, Che T, Xu Q, Jiang B, Chen J, Hay SI, Li Z, Gao GF, Wang L, Yang Y, Fang L, Liu W. Changes in notifiable infectious disease incidence in China during the COVID-19 pandemic. Nat Commun. 2021 Nov 26;12(1):6923. doi: 10.1038/s41467-021-27292-7. doi: 10.1038/s41467-021-27292-7.10.1038/s41467-021-27292-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-021-27292-7</ArticleId><ArticleId IdType="doi">10.1038/s41467-021-27292-7</ArticleId><ArticleId IdType="pmc">PMC8626444</ArticleId><ArticleId IdType="pubmed">34836947</ArticleId></ArticleIdList></Reference><Reference><Citation>Dong Y, Wang L, Burgner DP, Miller JE, Song Y, Ren X, Li Z, Xing Y, Ma J, Sawyer SM, Patton GC. Infectious diseases in children and adolescents in China: analysis of national surveillance data from 2008 to 2017. BMJ. 2020 Apr 02;369:m1043. doi: 10.1136/bmj.m1043. 
 
</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.m1043</ArticleId><ArticleId IdType="pmc">PMC7114954</ArticleId><ArticleId IdType="pubmed">32241761</ArticleId></ArticleIdList></Reference><Reference><Citation>National Bureau of Statistics of China. 2023.  [2024-04-10].  
 https://www.stats.gov.cn
.</Citation></Reference><Reference><Citation>Chen B, Wang M, Huang X, Xie M, Pan L, Liu H, Liu Z, Zhou P. Changes in incidence of notifiable infectious diseases in China under the prevention and control measures of COVID-19. Front Public Health. 2021 Oct 15;9:728768. doi: 10.3389/fpubh.2021.728768. 
 
</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpubh.2021.728768</ArticleId><ArticleId IdType="pmc">PMC8553983</ArticleId><ArticleId IdType="pubmed">34722440</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen J, Chen Y, Sun Y. Control of COVID-19 in China likely reduced the burden of multiple other infectious diseases. J Infect. 2022 Apr;84(4):579–613. doi: 10.1016/j.jinf.2022.01.001. 
 
S0163-4453(22)00001-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jinf.2022.01.001</ArticleId><ArticleId IdType="pmc">PMC8743852</ArticleId><ArticleId IdType="pubmed">35016903</ArticleId></ArticleIdList></Reference><Reference><Citation>Bai B, Jiang Q, Hou J. The COVID-19 epidemic and other notifiable infectious diseases in China. Microbes Infect. 2022 Feb;24(1):104881. doi: 10.1016/j.micinf.2021.104881. 
 
S1286-4579(21)00103-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.micinf.2021.104881</ArticleId><ArticleId IdType="pmc">PMC8375246</ArticleId><ArticleId IdType="pubmed">34419605</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen S, Zhang X, Zhou Y, Yang K, Lu X. COVID-19 protective measures prevent the spread of respiratory and intestinal infectious diseases but not sexually transmitted and bloodborne diseases. J Infect. 2021 Jul;83(1):e37–e39. doi: 10.1016/j.jinf.2021.04.018. 
 
S0163-4453(21)00204-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jinf.2021.04.018</ArticleId><ArticleId IdType="pmc">PMC8061184</ArticleId><ArticleId IdType="pubmed">33895225</ArticleId></ArticleIdList></Reference><Reference><Citation>Adegbija O, Walker J, Smoll N, Khan A, Graham J, Khandaker G. Notifiable diseases after implementation of COVID-19 public health prevention measures in Central Queensland, Australia. Commun Dis Intell (2018) 2021 Feb 26;:45. doi: 10.33321/cdi.2021.45.11. doi: 10.33321/cdi.2021.45.11.</Citation><ArticleIdList><ArticleId IdType="doi">10.33321/cdi.2021.45.11</ArticleId><ArticleId IdType="doi">10.33321/cdi.2021.45.11</ArticleId><ArticleId IdType="pubmed">33632091</ArticleId></ArticleIdList></Reference><Reference><Citation>Amar S, Avni YS, O'Rourke N, Michael T. Prevalence of common infectious diseases after COVID-19 vaccination and easing of pandemic restrictions in Israel. JAMA Netw Open. 2022 Feb 01;5(2):e2146175. doi: 10.1001/jamanetworkopen.2021.46175. 
 
2788557</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2021.46175</ArticleId><ArticleId IdType="pmc">PMC8808334</ArticleId><ArticleId IdType="pubmed">35103792</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Z, Wang P, Gao G, Xu C, Chen X. Age-period-cohort analysis of infectious disease mortality in urban-rural China, 1990-2010. Int J Equity Health. 2016 Mar 31;15(1):55. doi: 10.1186/s12939-016-0343-7. 
 
10.1186/s12939-016-0343-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12939-016-0343-7</ArticleId><ArticleId IdType="doi">10.1186/s12939-016-0343-7</ArticleId><ArticleId IdType="pmc">PMC4815076</ArticleId><ArticleId IdType="pubmed">27036223</ArticleId></ArticleIdList></Reference><Reference><Citation>de Lusignan S, McGee C, Webb R, Joy M, Byford R, Yonova I, Hriskova M, Matos Ferreira F, Elliot AJ, Smith G, Rafi I. Conurbation, urban, and rural living as determinants of allergies and infectious diseases: Royal College of General Practitioners Research and Surveillance Centre annual report 2016-2017. JMIR Public Health Surveill. 2018 Nov 26;4(4):e11354. doi: 10.2196/11354. 
 
v4i4e11354</Citation><ArticleIdList><ArticleId IdType="doi">10.2196/11354</ArticleId><ArticleId IdType="pmc">PMC6288591</ArticleId><ArticleId IdType="pubmed">30478022</ArticleId></ArticleIdList></Reference><Reference><Citation>Jones KE, Patel NG, Levy MA, Storeygard A, Balk D, Gittleman JL, Daszak P. Global trends in emerging infectious diseases. Nature. 2008 Feb 21;451(7181):990–3. doi: 10.1038/nature06536. 
 
nature06536</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature06536</ArticleId><ArticleId IdType="pmc">PMC5960580</ArticleId><ArticleId IdType="pubmed">18288193</ArticleId></ArticleIdList></Reference><Reference><Citation>Timpka T, Spreco A, Dahlström Örjan, Eriksson O, Gursky E, Ekberg J, Blomqvist E, Strömgren Magnus, Karlsson D, Eriksson H, Nyce J, Hinkula J, Holm E. Performance of eHealth data sources in local influenza surveillance: a 5-year open cohort study. J Med Internet Res. 2014 Apr 28;16(4):e116. doi: 10.2196/jmir.3099. 
 
v16i4e116</Citation><ArticleIdList><ArticleId IdType="doi">10.2196/jmir.3099</ArticleId><ArticleId IdType="pmc">PMC4019774</ArticleId><ArticleId IdType="pubmed">24776527</ArticleId></ArticleIdList></Reference><Reference><Citation>Sylvestre E, Cécilia-Joseph Elsa, Bouzillé Guillaume, Najioullah F, Etienne M, Malouines F, Rosine J, Julié Sandrine, Cabié André, Cuggia M. The role of heterogenous real-world data for dengue surveillance in Martinique: observational retrospective study. JMIR Public Health Surveill. 2022 Dec 22;8(12):e37122. doi: 10.2196/37122. 
 
v8i12e37122</Citation><ArticleIdList><ArticleId IdType="doi">10.2196/37122</ArticleId><ArticleId IdType="pmc">PMC9816958</ArticleId><ArticleId IdType="pubmed">36548023</ArticleId></ArticleIdList></Reference><Reference><Citation>Pesälä Samuli, Virtanen MJ, Sane J, Jousimaa J, Lyytikäinen Outi, Murtopuro S, Mustonen P, Kaila M, Helve O. Health care professionals' evidence-based medicine internet searches closely mimic the known seasonal variation of Lyme borreliosis: a register-based study. JMIR Public Health Surveill. 2017 Apr 11;3(2):e19. doi: 10.2196/publichealth.6764. 
 
v3i2e19</Citation><ArticleIdList><ArticleId IdType="doi">10.2196/publichealth.6764</ArticleId><ArticleId IdType="pmc">PMC5405287</ArticleId><ArticleId IdType="pubmed">28400357</ArticleId></ArticleIdList></Reference><Reference><Citation>Koch M, Matzke I, Huhn S, Sié Ali, Boudo V, Compaoré Guillaume, Maggioni MA, Bunker A, Bärnighausen Till, Dambach P, Barteit S. Assessing the effect of extreme weather on population health using consumer-grade wearables in rural Burkina Faso: observational panel study. JMIR Mhealth Uhealth. 2023 Nov 08;11:e46980. doi: 10.2196/46980. 
 
v11i1e46980</Citation><ArticleIdList><ArticleId IdType="doi">10.2196/46980</ArticleId><ArticleId IdType="pmc">PMC10666008</ArticleId><ArticleId IdType="pubmed">37938879</ArticleId></ArticleIdList></Reference><Reference><Citation>Ab Kadir MA, Abdul Manaf R, Mokhtar SA, Ismail LI. Spatio-temporal analysis of leptospirosis hotspot areas and its association with hydroclimatic factors in Selangor, Malaysia: protocol for an ecological cross-sectional study. JMIR Res Protoc. 2023 May 15;12:e43712. doi: 10.2196/43712. 
 
v12i1e43712</Citation><ArticleIdList><ArticleId IdType="doi">10.2196/43712</ArticleId><ArticleId IdType="pmc">PMC10227704</ArticleId><ArticleId IdType="pubmed">37184897</ArticleId></ArticleIdList></Reference><Reference><Citation>Jackson C, Mangtani P, Hawker J, Olowokure B, Vynnycky E. The effects of school closures on influenza outbreaks and pandemics: systematic review of simulation studies. PLoS One. 2014;9(5):e97297. doi: 10.1371/journal.pone.0097297. 
 
PONE-D-13-43115</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0097297</ArticleId><ArticleId IdType="doi">10.1371/journal.pone.0097297</ArticleId><ArticleId IdType="pmc">PMC4022492</ArticleId><ArticleId IdType="pubmed">24830407</ArticleId></ArticleIdList></Reference><Reference><Citation>Flaxman S, Mishra S, Gandy A, Unwin HJT, Mellan TA, Coupland H, Whittaker C, Zhu H, Berah T, Eaton JW, Monod M, Imperial College COVID-19 Response Team. Ghani AC, Donnelly CA, Riley S, Vollmer MAC, Ferguson NM, Okell LC, Bhatt S. Estimating the effects of non-pharmaceutical interventions on COVID-19 in Europe. Nature. 2020 Aug;584(7820):257–261. doi: 10.1038/s41586-020-2405-7.10.1038/s41586-020-2405-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-2405-7</ArticleId><ArticleId IdType="pubmed">32512579</ArticleId></ArticleIdList></Reference><Reference><Citation>Cohen R, Ashman M, Taha M, Varon E, Angoulvant F, Levy C, Rybak A, Ouldali N, Guiso N, Grimprel E. Pediatric Infectious Disease Group (GPIP) position paper on the immune debt of the COVID-19 pandemic in childhood, how can we fill the immunity gap? Infect Dis Now. 2021 Aug;51(5):418–423. doi: 10.1016/j.idnow.2021.05.004. 
 
S2666-9919(21)00112-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.idnow.2021.05.004</ArticleId><ArticleId IdType="pmc">PMC8114587</ArticleId><ArticleId IdType="pubmed">33991720</ArticleId></ArticleIdList></Reference><Reference><Citation>Xing W, Liao Q, Viboud C, Zhang J, Sun J, Wu JT, Chang Z, Liu F, Fang VJ, Zheng Y, Cowling BJ, Varma JK, Farrar JJ, Leung GM, Yu H. Hand, foot, and mouth disease in China, 2008-12: an epidemiological study. Lancet Infect Dis. 2014 Apr;14(4):308–318. doi: 10.1016/S1473-3099(13)70342-6. 
 
</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(13)70342-6</ArticleId><ArticleId IdType="pmc">PMC4035015</ArticleId><ArticleId IdType="pubmed">24485991</ArticleId></ArticleIdList></Reference><Reference><Citation>Braunstein SL, Slutsker JS, Lazar R, Shah D, Hennessy RR, Chen SX, Pathela P, Daskalakis DC, Schillinger JA. Epidemiology of reported HIV and other sexually transmitted infections during the COVID-19 pandemic, New York City. J Infect Dis. 2021 Sep 01;224(5):798–803. doi: 10.1093/infdis/jiab319. 
 
6301136</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiab319</ArticleId><ArticleId IdType="pmc">PMC8344782</ArticleId><ArticleId IdType="pubmed">34134130</ArticleId></ArticleIdList></Reference><Reference><Citation>Ullrich A, Schranz M, Rexroth U, Hamouda O, Schaade L, Diercke M, Boender TS, Robert Koch's Infectious Disease Surveillance Group  Impact of the COVID-19 pandemic and associated non-pharmaceutical interventions on other notifiable infectious diseases in Germany: An analysis of national surveillance data during week 1-2016 - week 32-2020. Lancet Reg Health Eur. 2021 Jul;6:100103. doi: 10.1016/j.lanepe.2021.100103. 
 
S2666-7762(21)00080-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lanepe.2021.100103</ArticleId><ArticleId IdType="pmc">PMC8454829</ArticleId><ArticleId IdType="pubmed">34557831</ArticleId></ArticleIdList></Reference><Reference><Citation>van Bilsen WPH, Zimmermann HML, Boyd A, Coyer L, van der Hoek L, Kootstra NA, Hoornenborg E, Prins M, Schim van der Loeff MF, Davidovich U, Matser A. Sexual behavior and its determinants during COVID-19 restrictions among men who have sex with men in Amsterdam. J Acquir Immune Defic Syndr. 2021 Mar 01;86(3):288–296. doi: 10.1097/QAI.0000000000002581. 
 
00126334-202103010-00004</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/QAI.0000000000002581</ArticleId><ArticleId IdType="pmc">PMC7879601</ArticleId><ArticleId IdType="pubmed">33230027</ArticleId></ArticleIdList></Reference><Reference><Citation>Li W, Li G, Xin C, Wang Y, Yang S. Challenges in the practice of sexual medicine in the time of COVID-19 in China. J Sex Med. 2020 Jul;17(7):1225–1228. doi: 10.1016/j.jsxm.2020.04.380. 
 
S1743-6095(20)30597-X</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jsxm.2020.04.380</ArticleId><ArticleId IdType="pmc">PMC7188657</ArticleId><ArticleId IdType="pubmed">32418751</ArticleId></ArticleIdList></Reference><Reference><Citation>Stanford KA, Almirol E, Schneider J, Hazra A. Rising syphilis rates during the COVID-19 pandemic. Sex Transm Dis. 2021 Jun 01;48(6):e81–e83. doi: 10.1097/OLQ.0000000000001431.00007435-202106000-00014</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/OLQ.0000000000001431</ArticleId><ArticleId IdType="pubmed">33783406</ArticleId></ArticleIdList></Reference><Reference><Citation>Tudor ME, Al Aboud AM, Leslie SW, Gossman W. StatPearls [Internet] Treasure Island, FL: StatPearls Publishing; 2024. Jan, Syphilis.</Citation></Reference><Reference><Citation>Wilder-Smith A. Dengue during the COVID-19 pandemic. J Travel Med. 2021 Dec 29;28(8):taab183. doi: 10.1093/jtm/taab183. 
 
6440804</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jtm/taab183</ArticleId><ArticleId IdType="pmc">PMC8690170</ArticleId><ArticleId IdType="pubmed">34850050</ArticleId></ArticleIdList></Reference><Reference><Citation>Barzon L, Gobbi F, Capelli G, Montarsi F, Martini S, Riccetti S, Sinigaglia A, Pacenti M, Pavan G, Rassu M, Padovan MT, Manfrin V, Zanella F, Russo F, Foglia F, Lazzarini L. Autochthonous dengue outbreak in Italy 2020: clinical, virological and entomological findings. J Travel Med. 2021 Dec 29;28(8):taab130. doi: 10.1093/jtm/taab130. 
 
6354471</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jtm/taab130</ArticleId><ArticleId IdType="pmc">PMC8499737</ArticleId><ArticleId IdType="pubmed">34409443</ArticleId></ArticleIdList></Reference><Reference><Citation>Petrovan SO, Aldridge DC, Bartlett H, Bladon AJ, Booth H, Broad S, Broom DM, Burgess ND, Cleaveland S, Cunningham AA, Ferri M, Hinsley A, Hua F, Hughes AC, Jones K, Kelly M, Mayes G, Radakovic M, Ugwu CA, Uddin N, Veríssimo Diogo, Walzer C, White TB, Wood JL, Sutherland WJ. Post COVID-19: a solution scan of options for preventing future zoonotic epidemics. Biol Rev Camb Philos Soc. 2021 Dec;96(6):2694–2715. doi: 10.1111/brv.12774. 
 
</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/brv.12774</ArticleId><ArticleId IdType="pmc">PMC8444924</ArticleId><ArticleId IdType="pubmed">34231315</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang H, Wang L, Lai S, Li Z, Sun Q, Zhang P. Surveillance and early warning systems of infectious disease in China: From 2012 to 2014. Int J Health Plann Manage. 2017 Jul;32(3):329–338. doi: 10.1002/hpm.2434.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/hpm.2434</ArticleId><ArticleId IdType="pubmed">28632912</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>